MDT vs URGN · P/E 21, rev $36.36B vs rev $109.8M
Medtronic PLC (MDT) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. URGN currently screens at market cap $1.61B.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. URGN currently screens at market cap $1.61B.
Not investment advice. Open the MDT and URGN stock pages for the full models.
Not investment advice.